Mark E. Tryniski - 01 Jun 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
Sarah M Oliker for Mark E. Tryniski by Power of Attorney
Issuer symbol
CNMD
Transactions as of
01 Jun 2022
Transactions value $
$0
Form type
4
Filing time
03 Jun 2022, 09:22:35 UTC
Previous filing
15 Mar 2023
Next filing
09 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +812 +9.79% $0.00 9.11K 01 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -812 -100% $0.00* 0 01 Jun 2022 Common Stock 812 $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Mark E. Tryniski is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.